Skip to main content
Premium Trial:

Request an Annual Quote

William Bennett, Ted Love.

Premium

Hyseq has appointed William Bennett as senior vice president of research.

Bennett previously worked with Hyseq CEO Ted Love at Genentech, where he served as team leader of the TNKase project and held numerous other R&D positions.

Since leaving Genentech, Bennett has held the positions of senior vice president, research and manufacturing at Sensus Drug Development, senior vice president for product development at BigBearBio, and vice president of research at COR Therapeutics.

Bennett received his PhD from University of Texas Southwestern Medical School, has authored 50 scientific publications, and holds 19 issued US patents.

At Sunnyvale, Calif.-based Hyseq, which has shifted its main focus recently from biochips to biopharmaceuticals (see p. 5), Bennett said he is planning to work on implementing the new strategy.

“Hyseq has discovered a large number of novel genes and the next step is moving candidates into the clinic. This is an important time in the company’s strategy of building a biopharmaceutical company and I look forward to playing a leading role,” Bennett said in a statement.

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.